A Mechanistic Study on the Destabilization of Whole Inactivated Influenza Virus Vaccine in Gastric Environment

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Choi, Hyo Jick ^a   Ebersbacher, Charles F ^a   Kim, Min Chul ^b,c   Kang, Sang Moo ^b   Montemagno, Carlo D ^d  

^a UNIVERSITY OF CINCINNATI   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INFLUENZA VACCINE;

ACIDITY; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DILUTION; DRUG RETENTION; DRUG STABILITY; DYNAMICS; FLUORESCENCE SPECTROSCOPY; GASTROINTESTINAL TRACT; HEMAGGLUTINATION TEST; HYPEROSMOTIC STRESS; ISOOSMOTIC STRESS; KINETICS; LIGHT SCATTERING; MEMBRANE STRUCTURE; OSMOTIC STRESS; PARTICLE SIZE; PH; TEMPERATURE SENSITIVITY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CHICKENS; HYDROGEN-ION CONCENTRATION; INFLUENZA VACCINES; LIPOSOMES; MICROSCOPY, ELECTRON, TRANSMISSION; OSMOTIC PRESSURE; SPECTROMETRY, FLUORESCENCE; TEMPERATURE; VACCINES, INACTIVATED;

ORTHOMYXOVIRIDAE;

EID: 84878854163     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066316     Document Type: Article

References (58)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, et al. (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289: 179-186.
2. Fauci AS, (2006) Emerging and re-emerging infectious diseases: Influenza as a prototype of the host-pathogen balancing act. Cell 124: 665-670.
3. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, et al. (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25: 5086-5096.
4. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB, (2004) Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 53: 1-40.
5. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, et al. (2010) Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 59: 1-62.
6. Keitel WA, Couch RB (2002) Inactivated influenza vaccines. In: Potter CW, editor. Perspectives in Medical Virology: Elsevier. 145-177.
7. Giudice EL, Campbell JD, (2006) Needle-free vaccine delivery. Adv Drug Deliv Rev 58: 68-89.
8. Neutra MR, Kozlowski PA, (2006) Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6: 148-158.
9. Palese P, (2006) Making better influenza virus vaccines? Emerg Infect Dis 12: 61-65.
10. Mutsch M, Zhou WG, Rhodes P, Bopp M, Chen RT, et al. (2004) Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 350: 896-903.
11. Farag-Mahmod FI, Wyde PR, Rosborough JP, Six HR, (1988) Immunogenicity and efficacy of orally administered inactivated influenza virus vaccine in mice. Vaccine 6: 262-268.
12. Lazzell V, Waldman RH, Rose C, Khakoo R, Jacknowitz A, et al. (1984) Immunization against influenza in humans using an oral enteric-coated killed virus-vaccine. J Biol Stand 12: 315-321.
13. Quan FS, Li ZN, Kim MC, Yang D, Compans RW, et al. (2011) Immunogenicity of low-pH treated whole viral influenza vaccine. Virology 417: 196-202.
14. Azizi A, Kumar A, Diaz-Mitoma F, Mestecky J, (2010) Enhancing oral vaccine potency by targeting intestinal M cells. PLoS Pathog 6: e1001147.
15. Shastri PN, Kim MC, Quan FS, D'Souza MJ, Kang SM, (2012) Immunogenicity and protection of oral influenza vaccines formulated into microparticles. J Pharm Sci 101: 3623-3635.
16. Rose EF, (1979) Factors influencing gastric emptying. J Forensic Sci 24: 200-206.
17. Hellmig S, Von Schoning F, Gadow C, Katsoulis S, Hedderich J, et al. (2006) Gastric emptying time of fluids and solids in healthy subjects determined by 13C breath tests: influence of age, sex and body mass index. J Gastroenterol Hepatol 21: 1832-1838.
18. Ong BY, Palahniuk RJ, Cumming M, (1978) Gastric volume and pH in out-patients. Can Anaesth Soc J 25: 36-39.
19. Schwarz H, Koch AL, (1995) Phase and electron microscopic observations of osmotically induced wrinkling and the role of endocytotic vesicles in the plasmolysis of the Gram-negative cell wall. Microbiology 141: 3161-3170.
20. Scheie PO, (1969) Plasmolysis of Escherichia Coli B/R with Sucrose. J Bacteriol 98: 335-340.
21. Waite MR, Pfefferkorn ER, (1968) Effect of altered osmotic pressure on the growth of Sindbis virus. J Virol 2: 759-760.
22. Colwell W, Simmons D, Harris J, Fulp T, Carrozza J, et al. (1975) Influence of some physical factors on survival of Marek's disease vaccine virus. Avian Dis: 781-790.
23. Skehel JJ, Bayley PM, Brown EB, Martin SR, Waterfield MD, et al. (1982) Changes in the conformation of influenza-virus hemagglutinin at the pH optimum of virus-mediated membrane-fusion. Proc Natl Acad Sci U S A 79: 968-972.
24. Bullough PA, Hughson FM, Skehel JJ, Wiley DC, (1994) Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371: 37-43.
25. Kates M, Allison A, Tyrrell D, James A, (1961) Lipids of influenza virus and their relation to those of the host cell. Biochim Biophys Acta 52: 455-466.
26. Blough HA, (1971) Fatty acid composition of individual phospholipids of influenza virus. J Gen Virol 12: 317-320.
27. Quan FS, Compans RW, Nguyen HH, Kang SM, (2008) Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J Virol 82: 1350-1359.
28. Woodle MC, Papahadjopoulos D (1989) [9] Liposome preparation and size characterization. In: Sidney Fleischer BF, editor. Method Enzymol: Academic Press. 193-217.
29. Lammert AM, Schmidt SJ, Day GA, (1998) Water activity and solubility of trehalose. Food Chem 61: 139-144.
30. Malmberg CG, Maryott AA, (1950) Dielectric constants of aqueous solutions of dextrose and sucrose. J Res Nat Bur Stand 45: 299-303.
31. Choi HJ, Ebersbacher CF, Quan FS, Montemagno CD, (2013) pH stability and comparative evaluation of ranaspumin-2 foam for application in biochemical reactors. Nanotechnology 24: 055603.
32. Sun ST, Milon A, Tanaka T, Ourisson G, Nakatani Y, (1986) Osmotic swelling of unilamellar vesicles by the stopped-flow light-scattering method-elastic properties of vesicles. Biochim Biophys Acta 860: 525-530.
33. Choi HJ, Bondy BJ, Yoo DG, Compans RW, Kang SM, et al. (2013) Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles. J Control Release 166: 159-171.
34. Kim CH, Macosko JC, Shin YK, (1998) The mechanism for low-pH-induced clustering of phospholipid vesicles carrying the HA2 ectodomain of influenza hemagglutinin. Biochemistry 37: 137-144.
35. Brown JD, Goekjian G, Poulson R, Valeika S, Stallknecht DE, (2009) Avian influenza virus in water: Infectivity is dependent on pH, salinity and temperature. Vet Microbiol 136: 20-26.
36. Rich GT, Sha'afi I, Romualdez A, Solomon AK, (1968) Effect of osmolality on the hydraulic permeability coefficient of red cells. J Gen Physiol 52: 941-954.
37. Fatouros DG, Antimisiaris SG, (2002) Effect of amphiphilic drugs on the stability and zeta-potential of their liposome formulations: A study with prednisolone, diazepam, and griseofulvin. J Colloid Interf Sci 251: 271-277.
38. Fatouros DG, Antimisiaris SG, (2001) Physicochemical properties of liposomes incorporating hydrochlorothiazide and chlorothiazide. J Drug Target 9: 61-74.
39. Elliott JR, Needham D, Dilger JP, Haydon DA, (1983) The effects of bilayer thickness and tension on gramicidin single-channel lifetime. Biochim Biophys Acta 735: 95-103.
40. Skehel J, Bizebard T, Bullough P, Hughson F, Knossow M,et al. Membrane fusion by influenza hemagglutinin; 1995. Cold Spring Harbor Laboratory Press. 573-580.
41. Wiley DC, Skehel JJ, (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56: 365-394.
42. Daniels R, Douglas A, Skehel J, Wiley D, (1983) Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J Gen Virol 64: 1657-1662.
43. Yewdell JW, Gerhard W, Bachi T, (1983) Monoclonal anti-hemagglutinin antibodies detect irreversible antigenic alterations that coincide with the acid activation of influenza-virus A/PR/834-mediated hemolysis. J Virol 48: 239-248.
44. Milon A, Lazrak T, Albrecht AM, Wolff G, Weill G, et al. (1986) Osmotic swelling of unilamellar vesicles by the stopped-flow light scattering method. Influence of vesicle size, solute, temperature, cholesterol and three α, ω-dihydroxycarotenoids. Biochim Biophys Acta 859: 1-9.
45. Bittman R, Leventhal AM, Karp S, Blau L, Tremblay PA, et al. (1981) Osmotic behavior of liposomes of phosphatidylcholine and phosphatidylsulfocholine as a function of lipid-concentration. Chem Phys Lipids 28: 323-335.
46. Ponder E, (1944) The osmotic behavior of crenated red cells. J Gen Physiol 27: 273-285.
47. Knowles CJ, Smith L, (1971) Effect of osmotic pressure of the medium on the volume of intact cells of Azotobacter vinelandii and on the rate of respiration. Biochim Biophys Acta 234: 144-152.
48. Staneková Z, Vareckova E, (2010) Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development. Virol J 7: 351.
49. Cox RJ, Brokstad KA, Ogra P, (2004) Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 59: 1-15.
50. Daniels RS, Douglas AR, Skehel JJ, Wiley DC, Naeve CW, et al. (1984) Antigenic analyses of influenza virus haemagglutinins with different receptor-binding specificities. Virology 138: 174-177.
51. Choi HJ, Yoo DG, Bondy BJ, Quan FS, Compans RW, et al. (2012) Stability of influenza vaccine coated onto microneedles. Biomaterials 33: 3756-3769.
52. Quan FS, Kim YC, Vunnava A, Yoo DG, Song JM, et al. (2010) Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol 84: 7760-7769.
53. Quan FS, Kim YC, Yoo DG, Compans RW, Prausnitz MR, et al. (2009) Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One 4: e7152.
54. Szarka LA, Camilleri M, (2009) Methods for measurement of gastric motility. Am J Physiol Gastrointest Liver Physiol 296: G461-475.
55. Hunt JN, (1959) Gastric emptying and secretion in man. Physiol Rev 39: 491-533.
56. Miller GL, (1944) Influence of pH and of certain other conditions on the stability of the infectivity and red cell agglutinating activity of influenza virus. J Exp Med 80: 507-520.
57. Hunt JN, (1959) Gastric emptying and secretion in man. Physiol Rev 39: 491-533.
58. McSwiney B, Spurrell W, (1933) Influence of osmotic pressure upon the emptying time of the stomach. J Physiol 79: 437-442.